PlainPharmaWatch

CMS Open Payments · Program Year 2024

Concordia Pharmaceuticals Inc.

Concordia Pharmaceuticals Inc. reported $255,000.00 across General Payments, Research, and Ownership to 3 physicians and teaching hospitals across 3 transactions.

See the rankings → How this is sourced
$255.0K
All-tracks total
3
Transactions
3
Recipients
#933
of 1,925 companies

Concordia Pharmaceuticals Inc. reported $255,000.00 across all CMS Open Payments tracks (General + Research + Ownership) to 3 physicians and teaching hospitals in Program Year 2024 - ranking #933 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $255,000.00, averaging $85.0K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer concordia-pharmaceuticals-inc Concordia Pharmaceuticals Inc.

$255.0K · #933/1,925 · 0.0% industry · PY2024

  • TOT $255.0K
  • RANK #933
  • SHARE 0.0%
  • TXN 3
  • RCP 3
  • CAT 1
  • GEN $255.0K
  • TOP1 100.0%
  • PY 2024

Volume peers

Nearest volume peer: Radical Catheter Technologies, Inc. ($255.2K)

FUJIFILM Sonosite, Inc.$257.0KQapel Medical Inc$256.6KRadical Catheter Technologie…$255.2KConcordia Pharmaceuticals In…$255.0KAidoc Medical Ltd$254.6K
All-tracks payment totals near Concordia Pharmaceuticals Inc. (CMS Open Payments PY2024)

Concordia Pharmaceuticals Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Concordia Pharmaceuticals Inc.

Averaging $85.0K per transaction and $85.0K per recipient, Concordia Pharmaceuticals Inc.'s Program Year 2024 total comes to $255,000.00 across 3 transactions and 3 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #933 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

3 transactions worth $255.0K make "Compensation for Services Other Than Consulting" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Concordia Pharmaceuticals Inc. made 1 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $255.0K, 100.0% of General Payments.

How Concordia Pharmaceuticals Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$255.0K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $255.0K 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $255,000.00 (100.0%) of $255,000.00 in this company's General Payments records across 1 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Concordia Pharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Massachusetts General Hospit…$255.0K
  1. 1

    Massachusetts General Hospital

    $255,000.00 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Concordia Pharmaceuticals Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Concordia Pharmaceuticals Inc..

Pfizer Investment Co., Ltd

HHI 10000

Elekta Medical Systems Ltda

HHI 10000

Kirwan Surgical Products LLC

HHI 10000

Xenco Medical LLC

HHI 10000

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Concordia Pharmaceuticals Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Concordia Pharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.